Forian Inc. (NASDAQ:FORA) Position Boosted by Canton Hathaway LLC

Canton Hathaway LLC grew its holdings in Forian Inc. (NASDAQ:FORAFree Report) by 2.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 269,650 shares of the company’s stock after purchasing an additional 6,125 shares during the period. Canton Hathaway LLC’s holdings in Forian were worth $582,000 as of its most recent SEC filing.

Separately, Caprock Group LLC purchased a new position in Forian during the second quarter valued at approximately $230,000. 19.25% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Roth Mkm reissued a “buy” rating and set a $5.00 target price on shares of Forian in a research note on Thursday, November 14th.

Read Our Latest Stock Report on Forian

Forian Price Performance

Shares of NASDAQ FORA opened at $2.16 on Monday. Forian Inc. has a one year low of $1.98 and a one year high of $4.15. The business’s 50-day moving average price is $2.11 and its two-hundred day moving average price is $2.41. The company has a market capitalization of $66.99 million, a P/E ratio of -24.00 and a beta of 1.09.

About Forian

(Free Report)

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.

Featured Stories

Want to see what other hedge funds are holding FORA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Forian Inc. (NASDAQ:FORAFree Report).

Institutional Ownership by Quarter for Forian (NASDAQ:FORA)

Receive News & Ratings for Forian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forian and related companies with MarketBeat.com's FREE daily email newsletter.